(Q28536748)

English

Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway

scientific article (publication date: 2013)

Statements

Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway (English)
0 references
Xue-Feng Wu
0 references
Rui Xu
0 references
Zi-Jun Ouyang
0 references
Cheng Qian
0 references
Yan Shen
0 references
Xu-Dong Wu
0 references
Yan-Hong Gu
0 references
Qiang Xu
0 references
Yang Sun
0 references
2013
0 references
0 references
8
0 references
12
0 references
e83013
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit